Figure 1
From: First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen?
Comparison of toxicities of AI vs tamoxifen from the ATAC trial (CA=cancer, DVT=deep venous thrombosis, M/S=musculoskeletal).
Figure 1 | British Journal of Cancer
